APA (7th ed.) Citation

Preston, I. R., Burger, C. D., Bartolome, S., Safdar, Z., Krowka, M., Sood, N., . . . Hill, N. S. (2020). Ambrisentan in portopulmonary hypertension: A multicenter, open-label trial. Journal of Heart & Lung Transplantation, 39(5), 464. https://doi.org/10.1016/j.healun.2019.12.008

Chicago Style (17th ed.) Citation

Preston, Ioana R., et al. "Ambrisentan in Portopulmonary Hypertension: A Multicenter, Open-label Trial." Journal of Heart & Lung Transplantation 39, no. 5 (2020): 464. https://doi.org/10.1016/j.healun.2019.12.008.

MLA (9th ed.) Citation

Preston, Ioana R., et al. "Ambrisentan in Portopulmonary Hypertension: A Multicenter, Open-label Trial." Journal of Heart & Lung Transplantation, vol. 39, no. 5, 2020, p. 464, https://doi.org/10.1016/j.healun.2019.12.008.